Nucleo

© 2025 Nucleo Research. All rights reserved.

Nucleo

© 2025 Nucleo Research. All rights reserved.

Nucleo

© 2025 Nucleo Research. All rights reserved.

Nucleo

© 2025 Nucleo Research. All rights reserved.

Nucleo

© 2025 Nucleo Research. All rights reserved.

Nucleo

Nucleo

Nucleo

Automated cancer diagnostics

Automated cancer diagnostics

We are Nucleo.

We automate CT scan analysis for oncology care.

0
1
2
3
4
5
6
7
8
9
,
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
x
Faster than manual segmentation.
0
1
2
3
4
5
6
7
8
9
,
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
x
Faster than manual segmentation.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
%
Agreement between Nucleo and experts.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
%
Agreement between Nucleo and experts.

This is Nucleo in action

We are backed by
We work with the best hospitals in the US and worldwide
Our technology is powered by industry leaders

Our use cases

Nucleo's AI technology streamlines clinical workflows across three critical areas for oncology care.

01

Body composition and sarcopenia assessment

Automatic detection and quantification of fat and muscle mass in CT scans.

01

Body composition and sarcopenia assessment

Automatic detection and quantification of fat and muscle mass in CT scans.

02

Tumor Lesion Sizing

Precise and consistent measurement of tumor lesions in CT scans.

02

Tumor Lesion Sizing

Precise and consistent measurement of tumor lesions in CT scans.

03

Target vs Non-Target Lesion Classification

Automated classification of lesions according to RECIST criteria.

03

Target vs Non-Target Lesion Classification

Automated classification of lesions according to RECIST criteria.

We want to hear from you.

Book some time with us, or send us a message.